Part D results
CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.
How to read this
Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.
Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.
CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.
| 2024 | 2023 | 2022 | 3-year total | Per member per year2024 | Part D members2024 avg | |
|---|---|---|---|---|---|---|
| H3449 Blue Cross and Blue Shield of North Carolina | $7.9M | $1.9M | $4.3M | $14.1M | $83 | 94,756 |
| H3404 Blue Cross and Blue Shield of North Carolina | $620K | $1.3M | $869K | $2.8M | $23 | 27,547 |
| H3777 Experience Health | $115K | $17.4K | $732K | $865K | $27 | 4,253 |
| H9147 Blue Cross and Blue Shield of North Carolina | $0 | $109K | $76.1K | $185K | $0 | 1,853 |
| S5540 Blue Cross and Blue Shield of North Carolina PDP | $0 | −$72.3K | $226K | $153K | $0 | 30,258 |
Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.